The Discounted Cash Flow (DCF) valuation of Ose Immunotherapeutics SA (OSE.PA) is 8.86 EUR. With the latest stock price at 5.91 EUR, the upside of Ose Immunotherapeutics SA based on DCF is 50.0%.
Based on the latest price of 5.91 EUR and our DCF valuation, Ose Immunotherapeutics SA (OSE.PA) is a buy. buying OSE.PA stocks now will result in a potential gain of 50.0%.
| Range | Selected | |
| WACC / Discount Rate | 7.5% - 9.6% | 8.6% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 7.39 - 11.02 | 8.86 |
| Upside | 25.0% - 86.5% | 50.0% |